170 related articles for article (PubMed ID: 17306059)
1. Differential gene expression analysis in antimony-unresponsive Indian kala azar (visceral leishmaniasis) clinical isolates by DNA microarray.
Singh N; Almeida R; Kothari H; Kumar P; Mandal G; Chatterjee M; Venkatachalam S; Govind MK; Mandal SK; Sundar S
Parasitology; 2007 Jun; 134(Pt 6):777-87. PubMed ID: 17306059
[TBL] [Abstract][Full Text] [Related]
2. The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India.
Singh N; Chatterjee M; Sundar S
Parasit Vectors; 2014 Dec; 7():596. PubMed ID: 25515494
[TBL] [Abstract][Full Text] [Related]
3. Novel mechanism of drug resistance in kala azar field isolates.
Singh N; Singh RT; Sundar S
J Infect Dis; 2003 Aug; 188(4):600-7. PubMed ID: 12898450
[TBL] [Abstract][Full Text] [Related]
4. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.
Mandal S; Maharjan M; Singh S; Chatterjee M; Madhubala R
J Antimicrob Chemother; 2010 Mar; 65(3):496-507. PubMed ID: 20067981
[TBL] [Abstract][Full Text] [Related]
5. Role of ABC transporter MRPA, gamma-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani.
Mukherjee A; Padmanabhan PK; Singh S; Roy G; Girard I; Chatterjee M; Ouellette M; Madhubala R
J Antimicrob Chemother; 2007 Feb; 59(2):204-11. PubMed ID: 17213267
[TBL] [Abstract][Full Text] [Related]
6. Increased parasite surface antigen-2 expression in clinical isolates of Leishmania donovani augments antimony resistance.
Bhandari V; Kumar D; Verma S; Srividya G; Negi NS; Singh R; Salotra P
Biochem Biophys Res Commun; 2013 Nov; 440(4):646-51. PubMed ID: 24103752
[TBL] [Abstract][Full Text] [Related]
7. Genetic markers for antimony resistant clinical isolates differentiation from Indian Kala-azar.
Khanra S; Sarraf NR; Das S; Das AK; Roy S; Manna M
Acta Trop; 2016 Dec; 164():177-184. PubMed ID: 27629023
[TBL] [Abstract][Full Text] [Related]
8. Genetic typing reveals monomorphism between antimony sensitive and resistant Leishmania donovani isolates from visceral leishmaniasis or post kala-azar dermal leishmaniasis cases in India.
Subba Raju BV; Gurumurthy S; Kuhls K; Bhandari V; Schnonian G; Salotra P
Parasitol Res; 2012 Oct; 111(4):1559-68. PubMed ID: 22752721
[TBL] [Abstract][Full Text] [Related]
9. Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani.
Samant M; Sahasrabuddhe AA; Singh N; Gupta SK; Sundar S; Dube A
Parasitology; 2007 Aug; 134(Pt 9):1175-84. PubMed ID: 17362540
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells.
Mukhopadhyay R; Mukherjee S; Mukherjee B; Naskar K; Mondal D; Decuypere S; Ostyn B; Prajapati VK; Sundar S; Dujardin JC; Roy S
Int J Parasitol; 2011 Nov; 41(13-14):1311-21. PubMed ID: 21920365
[TBL] [Abstract][Full Text] [Related]
11. Drug resistance mechanisms in clinical isolates of Leishmania donovani.
Singh N
Indian J Med Res; 2006 Mar; 123(3):411-22. PubMed ID: 16778320
[TBL] [Abstract][Full Text] [Related]
12. Leishmania donovani isolates with antimony-resistant but not -sensitive phenotype inhibit sodium antimony gluconate-induced dendritic cell activation.
Haldar AK; Yadav V; Singhal E; Bisht KK; Singh A; Bhaumik S; Basu R; Sen P; Roy S
PLoS Pathog; 2010 May; 6(5):e1000907. PubMed ID: 20502630
[TBL] [Abstract][Full Text] [Related]
13. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.
Singh R; Kumar D; Ramesh V; Negi NS; Singh S; Salotra P
J Infect Dis; 2006 Aug; 194(3):302-6. PubMed ID: 16826477
[TBL] [Abstract][Full Text] [Related]
14. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.
Lira R; Sundar S; Makharia A; Kenney R; Gam A; Saraiva E; Sacks D
J Infect Dis; 1999 Aug; 180(2):564-7. PubMed ID: 10395884
[TBL] [Abstract][Full Text] [Related]
15. Characterization of natural antimony resistance in Leishmania donovani isolates.
Mittal MK; Rai S; Ashutosh ; Ravinder ; Gupta S; Sundar S; Goyal N
Am J Trop Med Hyg; 2007 Apr; 76(4):681-8. PubMed ID: 17426170
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the proliferating cell nuclear antigen of Leishmania donovani clinical isolates and its association with antimony resistance.
Tandon R; Chandra S; Baharia RK; Das S; Misra P; Kumar A; Siddiqi MI; Sundar S; Dube A
Antimicrob Agents Chemother; 2014 Jun; 58(6):2997-3007. PubMed ID: 24614385
[TBL] [Abstract][Full Text] [Related]
17. Identification of a gene linked to drug resistance in field isolates of Leishmania donovani.
Singh N; Singh RT; Sundar S
Ann Trop Med Parasitol; 2002 Dec; 96(8):839-41. PubMed ID: 12625940
[No Abstract] [Full Text] [Related]
18. Over-Expression of Cysteine Leucine Rich Protein Is Related to SAG Resistance in Clinical Isolates of Leishmania donovani.
Das S; Shah P; Tandon R; Yadav NK; Sahasrabuddhe AA; Sundar S; Siddiqi MI; Dube A
PLoS Negl Trop Dis; 2015 Aug; 9(8):e0003992. PubMed ID: 26295340
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ABC transporters abolishes antimony resistance in Leishmania Infection.
Mookerjee Basu J; Mookerjee A; Banerjee R; Saha M; Singh S; Naskar K; Tripathy G; Sinha PK; Pandey K; Sundar S; Bimal S; Das PK; Choudhuri SK; Roy S
Antimicrob Agents Chemother; 2008 Mar; 52(3):1080-93. PubMed ID: 18056276
[TBL] [Abstract][Full Text] [Related]
20. Integrating genomics and proteomics permits identification of immunodominant antigens associated with drug resistance in human visceral leishmaniasis in India.
Singh N; Sundar S
Exp Parasitol; 2017 May; 176():30-45. PubMed ID: 28263760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
